Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 8
2011 2
2012 1
2013 2
2014 5
2015 4
2016 3
2017 5
2018 2
2019 3
2020 5
2021 3
2022 6
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Role of immunotherapy in Ewing sarcoma.
Morales E, Olson M, Iglesias F, Dahiya S, Luetkens T, Atanackovic D. Morales E, et al. Among authors: luetkens t. J Immunother Cancer. 2020 Dec;8(2):e000653. doi: 10.1136/jitc-2020-000653. J Immunother Cancer. 2020. PMID: 33293354 Free PMC article. Review.
Targeting the tumor microenvironment of Ewing sarcoma.
Morales E, Olson M, Iglesias F, Luetkens T, Atanackovic D. Morales E, et al. Among authors: luetkens t. Immunotherapy. 2021 Dec;13(17):1439-1451. doi: 10.2217/imt-2020-0341. Epub 2021 Oct 21. Immunotherapy. 2021. PMID: 34670399 Review.
Elotuzumab as a novel anti-myeloma immunotherapy.
Radhakrishnan SV, Bhardwaj N, Steinbach M, Weidner J, Luetkens T, Atanackovic D. Radhakrishnan SV, et al. Among authors: luetkens t. Hum Vaccin Immunother. 2017 Aug 3;13(8):1751-1757. doi: 10.1080/21645515.2017.1327487. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28604269 Free PMC article. Review.
Immunotherapies targeting CD38 in Multiple Myeloma.
Atanackovic D, Steinbach M, Radhakrishnan SV, Luetkens T. Atanackovic D, et al. Among authors: luetkens t. Oncoimmunology. 2016 Aug 5;5(11):e1217374. doi: 10.1080/2162402X.2016.1217374. eCollection 2016. Oncoimmunology. 2016. PMID: 27999737 Free PMC article. Review.
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma.
Hendrickson PG, Olson M, Luetkens T, Weston S, Han T, Atanackovic D, Fine GC. Hendrickson PG, et al. Among authors: luetkens t. Oncoimmunology. 2019 Oct 13;9(1):1673129. doi: 10.1080/2162402X.2019.1673129. eCollection 2020. Oncoimmunology. 2019. PMID: 32002284 Free PMC article. Review.
The role of surface molecule CD229 in Multiple Myeloma.
Olson M, Radhakrishnan SV, Luetkens T, Atanackovic D. Olson M, et al. Among authors: luetkens t. Clin Immunol. 2019 Jul;204:69-73. doi: 10.1016/j.clim.2018.10.006. Epub 2018 Oct 13. Clin Immunol. 2019. PMID: 30326256 Review.
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.
Atanackovic D, Radhakrishnan SV, Bhardwaj N, Luetkens T. Atanackovic D, et al. Among authors: luetkens t. Br J Haematol. 2016 Mar;172(5):685-98. doi: 10.1111/bjh.13889. Epub 2016 Jan 20. Br J Haematol. 2016. PMID: 26791002 Free article. Review.
48 results